5-Fluorouracil Nanoparticles Inhibit Hepatocellular Carcinoma via Activation of the p53 Pathway in the Orthotopic Transplant Mouse Model

• Mingrong Cheng,

  Affiliations Department of General Surgery, Zhoupu Hospital of Shanghai Pudong New Area, Shanghai, China, Department of General Surgery, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

  ⨯
• Bing He ,

  * E-mail: 2011cmr@sina.com (BH); wantao@whut.edu.cn (TW)

  Affiliation Department of General Surgery, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

  ⨯
• Tao Wan ,

  * E-mail: 2011cmr@sina.com (BH); wantao@whut.edu.cn (TW)

  Affiliation Biomedical Materials and Engineering Center, Wuhan University of Technology, Wuhan, China

  ⨯
• Weiping Zhu,

  Affiliation Department of General Surgery, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

  ⨯
• Jiang Han,

  Affiliation Department of General Surgery, Zhoupu Hospital of Shanghai Pudong New Area, Shanghai, China

  ⨯
• Bingbing Zha,

  Affiliation Department of Endocrine, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

  ⨯
• Houxiang Chen,

  Affiliation Biomedical Materials and Engineering Center, Wuhan University of Technology, Wuhan, China

  ⨯
• Fengxiao Yang,

  Affiliation Biomedical Materials and Engineering Center, Wuhan University of Technology, Wuhan, China

  ⨯
• Qing Li,

  Affiliation Department of General Medicine, Pujiang Hospital of Shanghai Fifth People’s Hospital, Shanghai, China

  ⨯
• Wei Wang,

  Affiliation Department of General Surgery, Zhoupu Hospital of Shanghai Pudong New Area, Shanghai, China

  ⨯
• Hongzhi Xu,

  Affiliation Department of General Surgery, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

  ⨯
• Tao Ye

  Affiliation Department of General Surgery, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

  ⨯